Immune cells link pregnancy and tumor spread

Individuals with cancer often do not die as a result of their initial tumor but as a result of tumors at distant sites that are derived from the initial tumor. Pregnancy is a condition that seems to be permissive for tumor dissemination, as breast tumors arising during pregnancy display a tendency for early spread to distant sites (metastasis). Research in mice, led by Ivan Stamenkovic, at the University of Lausanne, Switzerland, has now uncovered a possible reason for this.

Stamenkovic and colleagues found that the increased metastasis from tumors of several different types that they observed in pregnant mice was a result of decreased activity of immune cells known as NK cells. Furthermore, at least part of the inhibitory effect on NK cells was mediated by another group of immune cells, myeloid-derived suppressor cells.

Consistent with this, the of the lungs of pregnant mice (a site to which many of the tumors metastasized) was reflective of myeloid-derived suppressor cell accumulation. Of clinical interest, the majority of genes downregulated in the lungs of pregnant mice were also expressed at lower levels in samples from with poor prognosis than in samples from patients with better prognosis.

The authors therefore suggest that myeloid-derived suppressor cells may represent a shared mechanism of immune suppression during pregnancy and tumor growth.


Explore further

Mechanism for esophageal cancer uncovered

More information: www.jci.org/articles/view/4193 … bfc78b4e21ad3bc01f34
Provided by Journal of Clinical Investigation
Citation: Immune cells link pregnancy and tumor spread (2011, June 6) retrieved 18 June 2019 from https://medicalxpress.com/news/2011-06-immune-cells-link-pregnancy-tumor.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more